Literature DB >> 32473960

Long noncoding RNA loss in immune suppression in cancer.

Qingsong Hu1, Sergey D Egranov2, Chunru Lin3, Liuqing Yang4.   

Abstract

Long noncoding RNAs (lncRNAs) have multiple functions in the regulation of cellular homeostasis. In recent years, numerous studies have shown that tumor-associated lncRNAs play key roles in promoting and maintaining tumor initiation and progression by shaping the tumor microenvironment through changing tumor cell intrinsic properties. Here, we focus on the roles of lncRNAs in cancer immunology. In the first part, we provide an overview of the roles played by lncRNAs and their deregulation in cancer at the cancer cell- and tumor microenvironment-associated immune cell levels. We go on to describe preclinical strategies for targeting lncRNAs, particularly highlighting the effects on tumor microenvironments. We then discuss the possibility of combining lncRNA targeting and tumor immune checkpoint inhibitor antibodies to treat cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer immunotherapy; Long noncoding RNA; Tumor-cell-extrinsic factors; Tumor-cell-intrinsic factors

Mesh:

Substances:

Year:  2020        PMID: 32473960      PMCID: PMC7434710          DOI: 10.1016/j.pharmthera.2020.107591

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  167 in total

Review 1.  Liposomal siRNA nanocarriers for cancer therapy.

Authors:  Bulent Ozpolat; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Adv Drug Deliv Rev       Date:  2013-12-30       Impact factor: 15.470

Review 2.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

Authors:  Padmanee Sharma; Siwen Hu-Lieskovan; Jennifer A Wargo; Antoni Ribas
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 3.  Dendritic cells in cancer immunology and immunotherapy.

Authors:  Stefanie K Wculek; Francisco J Cueto; Adriana M Mujal; Ignacio Melero; Matthew F Krummel; David Sancho
Journal:  Nat Rev Immunol       Date:  2019-08-29       Impact factor: 53.106

Review 4.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

5.  Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells.

Authors:  Liying Yan; Mingyu Yang; Hongshan Guo; Lu Yang; Jun Wu; Rong Li; Ping Liu; Ying Lian; Xiaoying Zheng; Jie Yan; Jin Huang; Ming Li; Xinglong Wu; Lu Wen; Kaiqin Lao; Ruiqiang Li; Jie Qiao; Fuchou Tang
Journal:  Nat Struct Mol Biol       Date:  2013-08-11       Impact factor: 15.369

6.  AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.

Authors:  David Hong; Razelle Kurzrock; Youngsoo Kim; Richard Woessner; Anas Younes; John Nemunaitis; Nathan Fowler; Tianyuan Zhou; Joanna Schmidt; Minji Jo; Samantha J Lee; Mason Yamashita; Steven G Hughes; Luis Fayad; Sarina Piha-Paul; Murali V P Nadella; Morvarid Mohseni; Deborah Lawson; Corinne Reimer; David C Blakey; Xiaokun Xiao; Jeff Hsu; Alexey Revenko; Brett P Monia; A Robert MacLeod
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

Review 7.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

8.  LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.

Authors:  Shuquan Wei; Kangwei Wang; Xiaomei Huang; Zhuxiang Zhao; Ziwen Zhao
Journal:  Int J Immunopathol Pharmacol       Date:  2019 Jan-Dec       Impact factor: 3.219

Review 9.  Long Non-Coding RNA and Breast Cancer.

Authors:  Tianzhu Zhang; Hui Hu; Ge Yan; Tangwei Wu; Shuiyi Liu; Weiqun Chen; Yong Ning; Zhongxin Lu
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

10.  LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3.

Authors:  Peipei Fang; Luxia Xiang; Weilai Chen; Shaoxun Li; Shanshan Huang; Jie Li; Lu Zhuge; Lingxiang Jin; Wenke Feng; Yiping Chen; Chenwei Pan
Journal:  Innate Immun       Date:  2019-02       Impact factor: 2.680

View more
  20 in total

1.  Dysregulated Immune and Metabolic Microenvironment Is Associated with the Post-Operative Relapse in Stage I Non-Small Cell Lung Cancer.

Authors:  Shirong Zhang; Xiao Xiao; Xiuli Zhu; Xueqin Chen; Xiaochen Zhang; Jingjing Xiang; Rujun Xu; Zhuo Shao; Jing Bai; Yanping Xun; Yanping Jiang; Zhengzheng Chen; Xuefeng Xia; Hong Jiang; Shenglin Ma
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

2.  Long non-coding RNA small nucleolar RNA host gene 7 facilitates the proliferation, migration, and invasion of esophageal cancer cells by regulating microRNA-625.

Authors:  Yuan Wang; Dengke Bao; Lixin Wan; Chenghui Zhang; Shuang Hui; Hongqiang Guo
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 3.  The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.

Authors:  Yongcan Xu; Mantang Qiu; Minmin Shen; Shunli Dong; Guochao Ye; Xuefei Shi; Ming Sun
Journal:  Mol Ther       Date:  2021-03-26       Impact factor: 12.910

4.  Novel lncRNA UPLA1 mediates tumorigenesis and prognosis in lung adenocarcinoma.

Authors:  Xiaoyang Han; Hua Jiang; Jianni Qi; Jiamei Li; Jinghan Yang; Yingying Tian; Wei Li; Qi Jing; Chuanxi Wang
Journal:  Cell Death Dis       Date:  2020-11-21       Impact factor: 8.469

5.  LncRNA AC010789.1 Promotes Colorectal Cancer Progression by Targeting MicroRNA-432-3p/ZEB1 Axis and the Wnt/β-Catenin Signaling Pathway.

Authors:  Weili Duan; Xue Kong; Juan Li; Peilong Li; Yinghui Zhao; Tong Liu; Helen Barong Binang; Yunshan Wang; Lutao Du; Chuanxin Wang
Journal:  Front Cell Dev Biol       Date:  2020-10-15

6.  LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer via Mediating miR-137/E2F7 Axis.

Authors:  Guang-Yin Zhao; Zhao-Feng Ning; Rui Wang
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

Review 7.  The emerging roles of exosomal long non-coding RNAs in bladder cancer.

Authors:  Qiang Liu
Journal:  J Cell Mol Med       Date:  2022-01-03       Impact factor: 5.310

Review 8.  Long noncoding RNA: a dazzling dancer in tumor immune microenvironment.

Authors:  Yalu Zhang; Qiaofei Liu; Quan Liao
Journal:  J Exp Clin Cancer Res       Date:  2020-11-04

9.  Exosomal lncRNA ROR1-AS1 Derived from Tumor Cells Promotes Glioma Progression via Regulating miR-4686.

Authors:  Yang Chai; Hai-Tao Wu; Chuan-Dong Liang; Chun-Yue You; Ming-Xiang Xie; Shun-Wu Xiao
Journal:  Int J Nanomedicine       Date:  2020-11-10

10.  LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.

Authors:  Ting Liu; Chunli Yang; Weizhen Wang; Chunmei Liu
Journal:  Thorac Cancer       Date:  2021-06-01       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.